Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-01 Sale |
2024-10-03 4:58 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $6.2156 | $71,150 | 7,098,428 (Direct) |
View |
| 2024-09-26 Sale |
2024-09-30 6:15 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $7.0008 | $42,005 | 2,175,187 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 5:48 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $6.8431 | $78,333 | 7,109,875 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 6:28 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $6.2409 | $187,229 | 3,990,788 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 4:57 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $6.09 | $243,600 | 16,165,367 (Indirect Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 5:25 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $6.2652 | $71,718 | 7,121,322 (Direct) |
View |
| 2024-08-29 Sale |
2024-09-03 4:48 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $7.5627 | $45,376 | 2,181,187 (Direct) |
View |
| 2024-08-20 Sale |
2024-08-22 6:48 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $7.1226 | $81,532 | 7,132,769 (Direct) |
View |
| 2024-08-13 Sale |
2024-08-15 5:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $6.3478 | $190,434 | 4,111,500 (Direct) |
View |
| 2024-08-07 Sale |
2024-08-09 4:56 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
50,000 | $6.86 | $343,000 | 16,271,449 (Indirect Direct) |
View |
| 2024-08-06 Sale |
2024-08-08 5:23 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $6.8213 | $78,083 | 7,144,216 (Direct) |
View |
| 2024-07-25 Sale |
2024-07-29 6:16 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $8.1349 | $48,809 | 2,201,506 (Direct) |
View |
| 2024-07-23 Sale |
2024-07-25 6:15 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $8.4774 | $97,041 | 7,155,663 (Direct) |
View |
| 2024-07-10 Sale |
2024-07-12 6:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $7.475 | $747,500 | 16,401,449 (Indirect Direct) |
View |
| 2024-07-09 Sale |
2024-07-11 4:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $7.2785 | $218,354 | 4,220,250 (Direct) |
View |
| 2024-07-09 Sale |
2024-07-11 4:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $7.315 | $83,735 | 7,167,110 (Direct) |
View |
| 2024-06-27 Sale |
2024-06-28 5:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $7.215 | $43,290 | 2,207,506 (Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 7:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $9.5052 | $108,806 | 7,177,116 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 5:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $9.296 | $278,880 | 4,329,000 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 5:36 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $8.4531 | $96,763 | 7,188,563 (Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 4:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $8.71 | $871,000 | 10,249,749 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-01 Option Award |
2024-10-04 6:29 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,925 | $0 | 3,188,547 (Direct) |
View |
| 2024-09-26 Exercise |
2024-09-30 6:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $1.06 | 2,175,187 (Direct) |
View |
| 2024-09-26 Exercise |
2024-09-30 6:15 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
0 | $0 | 2,175,187 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-12 6:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 3,990,788 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-12 6:28 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 3,990,788 (Direct) |
View |
| 2024-09-04 Conversion |
2024-09-06 4:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 16,165,367 (Direct) |
View |
| 2024-08-29 Exercise |
2024-09-03 4:48 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $1.06 | 2,181,187 (Direct) |
View |
| 2024-08-29 Exercise |
2024-09-03 4:48 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $0 | 2,181,187 (Direct) |
View |
| 2024-08-30 Exercise |
2024-08-30 4:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-30 Exercise |
2024-08-30 4:26 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-29 Exercise |
2024-08-29 4:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-29 Exercise |
2024-08-29 4:22 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-28 4:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-28 4:12 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-27 4:10 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-27 4:10 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-26 4:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-26 4:42 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-23 5:25 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-23 5:25 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-15 Tax Withholding |
2024-08-19 7:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
14,319 | $6.69 | 2,187,187 (Direct) |
View |
| 2024-08-15 Tax Withholding |
2024-08-19 7:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer |
14,146 | $6.69 | 710,579 (Direct) |
View |
| 2024-08-15 Tax Withholding |
2024-08-19 7:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
26,082 | $6.69 | 10,048,667 (Direct) |
View |
| 2024-08-15 Tax Withholding |
2024-08-19 7:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
11,962 | $6.69 | 3,486,278 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 5:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 4,111,500 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 5:24 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 4,111,500 (Direct) |
View |
| 2024-08-07 Conversion |
2024-08-09 4:56 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
50,000 | $0 | 16,271,449 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-05 5:12 pm |
N/A 2034-08-01 |
RECURSION PHARMACEUTICALS INC. | RXRX | Khan Najat Chief R&D Commercial Officer |
1,490,916 | $0 | 1,490,916 (Direct) |
View |
| 2024-07-25 Exercise |
2024-07-29 6:16 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $1.06 | 2,201,506 (Direct) |
View |
| 2024-07-25 Exercise |
2024-07-29 6:16 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $0 | 2,201,506 (Direct) |
View |
| 2024-07-10 Gift |
2024-07-12 6:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 16,401,449 (Direct) |
View |
| 2024-07-10 Conversion |
2024-07-12 6:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $0 | 16,401,449 (Direct) |
View |
| 2024-06-05 Conversion(A) |
2024-07-12 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $0 | 7,235,438 (Direct) |
View |
| 2024-07-09 Exercise |
2024-07-11 4:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 4,220,250 (Direct) |
View |
| 2024-07-09 Exercise |
2024-07-11 4:51 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 4,220,250 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,592 | $0 | 3,186,622 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,843 | $0 | 103,996 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,843 | $0 | 71,254 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
1,441 | $0 | 7,178,557 (Direct) |
View |
| 2024-06-27 Exercise |
2024-06-28 5:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $1.06 | 2,207,506 (Direct) |
View |
| 2024-06-27 Exercise |
2024-06-28 5:14 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $0 | 2,207,506 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-17 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 4,329,000 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-17 5:46 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 4,329,000 (Direct) |
View |
| 2024-06-05 Gift |
2024-06-07 4:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,249,749 (Direct) |
View |
| 2024-06-05 Conversion |
2024-06-07 4:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,249,749 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:12 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
39,290 | $0 | 95,604 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:12 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
39,290 | $0 | 77,909 (Direct) |
View |